de Deutsche Bank Vertex Pharmaceuticals VRTX Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 886 M | Comprar |
1,695,541
+116,431
| +7% | +USD 59.6 M | 0.24% | 87 |
|
|
2026
Q2 | USD 784 M | Comprar |
1,579,110
+41,374
| +3% | +USD 18.3 M | 0.23% | 91 |
|
|
2026
Q1 | USD 687 M | Vender |
1,537,736
-231,145
| -13% | -USD 108 M | 0.23% | 92 |
|
|
2025
Q4 | USD 802 M | Comprar |
1,768,881
+168,425
| +11% | +USD 72.6 M | 0.26% | 79 |
|
|
2025
Q3 | USD 627 M | Comprar |
1,600,456
+192,822
| +14% | +USD 80.6 M | 0.21% | 100 |
|
|
2025
Q2 | USD 627 M | Comprar |
1,407,634
+60,748
| +5% | +USD 28 M | 0.23% | 92 |
|
|
2025
Q1 | USD 653 M | Vender |
1,346,886
-42,719
| -3% | -USD 19.9 M | 0.26% | 77 |
|
|
2024
Q4 | USD 560 M | Comprar |
1,389,605
+76,695
| +6% | +USD 35.6 M | 0.22% | 92 |
|
|
2024
Q3 | USD 611 M | Vender |
1,312,910
-66,410
| -5% | -USD 31.9 M | 0.25% | 81 |
|
|
2024
Q2 | USD 647 M | Vender |
1,379,320
-197,541
| -13% | -USD 85.7 M | 0.29% | 66 |
|
|
2024
Q1 | USD 659 M | Vender |
1,576,861
-69,804
| -4% | -USD 29.5 M | 0.31% | 65 |
|
|
2023
Q4 | USD 670 M | Comprar |
1,646,665
+320,297
| +24% | +USD 118 M | 0.34% | 58 |
|
|
2023
Q3 | USD 461 M | Vender |
1,326,368
-270,232
| -17% | -USD 94.5 M | 0.3% | 75 |
|
|
2023
Q2 | USD 562 M | Vender |
1,596,600
-159,560
| -9% | -USD 53.8 M | 0.3% | 75 |
|
|
2023
Q1 | USD 553 M | Vender |
1,756,160
-96,922
| -5% | -USD 29.1 M | 0.31% | 76 |
|
|
2022
Q4 | USD 535 M | Comprar |
1,853,082
+25,625
| +1% | +USD 7.81 M | 0.31% | 76 |
|
|
2022
Q3 | USD 529 M | Vender |
1,827,457
-213,715
| -10% | -USD 61.5 M | 0.32% | 72 |
|
|
2022
Q2 | USD 575 M | Vender |
2,041,172
-107,454
| -5% | -USD 28.8 M | 0.32% | 68 |
|
|
2022
Q1 | USD 561 M | Vender |
2,148,626
-410,687
| -16% | -USD 97.5 M | 0.26% | 82 |
|
|
2021
Q4 | USD 562 M | Vender |
2,559,313
-127,278
| -5% | -USD 24.7 M | 0.25% | 84 |
|
|
2021
Q3 | USD 487 M | Vender |
2,686,591
-47,319
| -2% | -USD 9.24 M | 0.23% | 96 |
|
|
2021
Q2 | USD 551 M | Comprar |
2,733,910
+694,871
| +34% | +USD 145 M | 0.27% | 80 |
|
|
2021
Q1 | USD 438 M | Comprar |
2,039,039
+783,218
| +62% | +USD 172 M | 0.24% | 86 |
|
|
2020
Q4 | USD 297 M | Comprar |
1,255,821
+236,046
| +23% | +USD 54.2 M | 0.18% | 116 |
|
|
2020
Q3 | USD 278 M | Comprar |
1,019,775
+116,703
| +13% | +USD 32.2 M | 0.19% | 112 |
|
|
2020
Q2 | USD 262 M | Vender |
903,072
-36,239
| -4% | -USD 9.8 M | 0.2% | 104 |
|
|
2020
Q1 | USD 224 M | Vender |
939,311
-532,686
| -36% | -USD 122 M | 0.2% | 99 |
|
|
2019
Q4 | USD 322 M | Vender |
1,471,997
-7,738
| -0.5% | -USD 1.57 M | 0.21% | 93 |
|
|
2019
Q3 | USD 251 M | Vender |
1,479,735
-320,786
| -18% | -USD 56.7 M | 0.17% | 124 |
|
|
2019
Q2 | USD 330 M | Comprar |
1,800,521
+403,803
| +29% | +USD 70.6 M | 0.19% | 101 |
|
|
2019
Q1 | USD 257 M | Comprar |
1,396,718
+432,709
| +45% | +USD 79.9 M | 0.15% | 138 |
|
|
2018
Q4 | USD 160 M | Vender |
964,009
-332,854
| -26% | -USD 57.7 M | 0.11% | 184 |
|
|
2018
Q3 | USD 250 M | Vender |
1,296,863
-84,362
| -6% | -USD 15 M | 0.13% | 155 |
|
|
2018
Q2 | USD 235 M | Comprar |
1,381,225
+41,544
| +3% | +USD 6.44 M | 0.12% | 174 |
|
|
2018
Q1 | USD 218 M | Comprar |
1,339,681
+407,204
| +44% | +USD 66.5 M | 0.1% | 195 |
|
|
2017
Q4 | USD 140 M | Vender |
932,477
-59,309
| -6% | -USD 8.78 M | 0.09% | 240 |
|
|
2017
Q3 | USD 151 M | Comprar |
991,786
+205,898
| +26% | +USD 31 M | 0.1% | 208 |
|
|
2017
Q2 | USD 101 M | Vender |
785,888
-388,987
| -33% | -USD 46.8 M | 0.07% | 308 |
|
|
2017
Q1 | USD 128 M | Comprar |
1,174,875
+40,805
| +4% | +USD 3.59 M | 0.09% | 241 |
|
|
2016
Q4 | USD 83.5 M | Vender |
1,134,070
-194,159
| -15% | -USD 15.8 M | 0.07% | 331 |
|
|
2016
Q3 | USD 116 M | Vender |
1,328,229
-54,153
| -4% | -USD 5.12 M | 0.08% | 281 |
|
|
2016
Q2 | USD 119 M | Comprar |
1,382,382
+187,908
| +16% | +USD 16.2 M | 0.08% | 279 |
|
|
2016
Q1 | USD 94.9 M | Vender |
1,194,474
-102,111
| -8% | -USD 9.24 M | 0.07% | 312 |
|
|
2015
Q4 | USD 163 M | Comprar |
1,296,585
+334,954
| +35% | +USD 40.4 M | 0.11% | 203 |
|
|
2015
Q3 | USD 100 M | Vender |
961,631
-206,384
| -18% | -USD 26.5 M | 0.08% | 296 |
|
|
2015
Q2 | USD 144 M | Comprar |
1,168,015
+54,317
| +5% | +USD 6.84 M | 0.09% | 259 |
|
|
2015
Q1 | USD 131 M | Vender |
1,113,698
-67,699
| -6% | -USD 8.11 M | 0.08% | 287 |
|
|
2014
Q4 | USD 140 M | Vender |
1,181,397
-1,252,621
| -51% | -USD 141 M | 0.09% | 278 |
|
|
2014
Q3 | USD 273 M | Comprar |
2,434,018
+233,581
| +11% | +USD 22.2 M | 0.17% | 131 |
|
|
2014
Q2 | USD 208 M | Vender |
2,200,437
-31,561
| -1% | -USD 2.21 M | 0.14% | 170 |
|
|
2014
Q1 | USD 158 M | Comprar |
2,231,998
+825,842
| +59% | +USD 65.4 M | 0.11% | 216 |
|
|
2013
Q4 | USD 104 M | Vender |
1,406,156
-193,073
| -12% | -USD 13.4 M | 0.08% | 297 |
|
|
2013
Q3 | USD 121 M | Comprar |
1,599,229
+521,804
| +48% | +USD 41.5 M | 0.09% | 262 |
|
|
2013
Q2 | USD 86.3 M | Comprar |
+1,077,425
| Nuevas | +USD 79.3 M | 0.07% | 314 |
|
Otros fondos que tienen VRTX en su cartera
Posición de Deutsche Bank en VRTX: resumen de T3 2026
Deutsche Bank aumentó su participación en Vertex Pharmaceuticals (VRTX) en 7.4% durante T3 2026, al comprar aproximadamente USD 59.6 M y elevar la posición a 1,695,541 acciones con un valor de USD 886 M. La posición representa 0.24% de la cartera y ocupa el puesto #87.
Deutsche Bank reportó por primera vez una posición en VRTX en T2 2013 y la ha mantenido durante 54 trimestres desde entonces. Al cierre de T3 2026, 1,556 fondos que sigue Wall St. Rank mantienen una posición en VRTX.
- Al cierre de T3 2026, Deutsche Bank tenía 1,695,541 acciones de Vertex Pharmaceuticals con un valor de USD 886 M.
- Deutsche Bank compró 116,431 acciones de Vertex Pharmaceuticals en T3 2026, por un monto estimado de USD 59.6 M.
- Vertex Pharmaceuticals representó 0.24% de la cartera de Deutsche Bank en T3 2026 y fue su posición número 87.
- Deutsche Bank reportó por primera vez una posición en Vertex Pharmaceuticals en T2 2013 y la ha mantenido durante 54 trimestres desde entonces.
- Al cierre de T3 2026, 1,556 fondos que sigue Wall St. Rank tenían Vertex Pharmaceuticals en cartera.
Según el Informe 13F de Deutsche Bank correspondiente a T3 2026, presentado el 6 nov 2026.